Videos
Articles
Citations: 3335
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Citations: 2330
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478
Citations: 1328
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 1300
A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force
Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824
Citations: 885
Position Paper - Allergen Standardization and Skin-Tests
Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54
Citations: 794
Allergenic pollen and pollen allergy in Europe
D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990
Citations: 760
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316
Citations: 757
The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887
Citations: 664
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948
Citations: 617
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025
Citations: 1590
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 350
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 179
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 167
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 164
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 77
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 56
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Citations: 55
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 52
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021
Transcriptome-based identification of novel endotypes in adult atopic dermatitis
Lefèvre-Utile, A., Saichi, M., Oláh, P., et al. Allergy. First published: 24 October 2021
Next-Generation Sequencing and Genotype Association Studies Reveal the Association of HLA-DRB3*02:02 With Delayed Hypersensitivity to Penicillins
Romano, A., Oussalah, A., Chery, C., et al. Allergy. First published: 23 October 2021
The Benefit of Late Readings in Patch Testing Depends both on Allergen and Patient Characteristics
Forkel, S., Schubert, S., Dickel, H., et al. Allergy. First published: 23 October 2021
Increased circulating CRTH2+Tregs are associated with asthma control and exacerbation
Chantveerawong, T., Sangkangjanavanich, S., Chiewchalermsri, C., et al. Allergy. First published: 22 October 2021
Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC)
Haya, L., Mehri, R., Somers-Neal, S., et al. Allergy. First published: 17 October 2021
Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England
Sousa-Pinto, B., Antó, J.M., Sheikh, A., et al. Allergy. First published: 19 October 2021
CD103 integrin identifies a high IL-10-producing FoxP3+ regulatory T cell population suppressing allergic airway inflammation
Tagkareli, S., Salagianni, M., Galani, I.-E., et al. Allergy. First published: 17 October 2021
Needle-free Epicutaneous For t 2 DNA Vaccine is Effective for Preventing and Treating Biting Midge (Forcipomyia taiwana) allergy in a murine model
Lee, M.F., Wu, C.-S., Lin, S.-J. and Chen, Y.-H. Allergy. First published: 15 October 2021
RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 Outbreaks
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021
Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper IgE syndromes
Garib, V., Ben-Ali, M., Kundi, M., et al. Allergy. First published: 15 October 2021
A Systematic Review of Parent Report Measures Assessing the Psychosocial Impact of Food Allergy on Patients and Families
Proctor, K.B., Tison, K., Estrem, H., et al. Allergy. First published: 13 October 2021
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19
Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021
Engineered IL-10: a matter of affinity
Fernandez-Santamaria, R. and Satitsuksanoa, P. Allergy. First published: 09 October 2021
Real-life observational cohort verifies high efficacy of dupilumab for Chronic Rhinosinusitis with Nasal Polyps
van der Lans, R.J.L., Fokkens, W.J., Adriaensen, G.F.J.P.M., et al. Allergy. First published: 09 October 2021
Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: a systematic review and meta-analysis
Vlieg- Boerstra, B., de Jong, N., Meyer, R., et al. Allergy. First published: 09 October 2021
Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort
Adjibade, M., Davisse-Paturet, C., Bernard, J.Y., et al. Allergy. First published: 09 October 2021
Advances and highlights in T and B cell responses to drug antigens
Fernandez-Santamaria, R., Ariza, A., Fernandez, T., Cespedes, J., Labella, M., Mayorga, C. and Torres, M. Allergy. First published: 07 October 2021
Virus-like particles displaying recombinant Der p 1 zymogen to optimize IgG blocking antibody response
Jitthamstaporn, S., Sander, A.F. and Jacquet, A. Allergy. First published: 07 October 2021
Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis
Uchida, A.M., Lenehan, P.J., Vimalathas, P., et al. Allergy. First published: 06 October 2021
Allergic eye disease: blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
Eskandarpour, M., Zhang, X., Micera, A., et al. Allergy. First published: 06 October 2021
No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge
Álvarez García, O., Bartra, J., Ruiz-Garcia, M., et al. Allergy. First published: 06 October 2021
The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management
Papi, A., Jesenak, M., Alfano, F., Peroni, D., Baraldi, F. and Diamant, Z. Allergy. First published: 06 October 2021
Legends of Allergy and Immunology: Giorgio Walter Canonica- physician, scientist and visionary leader
Heffler, E., Passalacqua, G. and Moretta, L. Allergy. First published: 05 October 2021
Identification of Chronic Urticaria Subtypes Using Machine Learning Algorithms
Türk, M., Ertaş, R., Zeydan, E., et al. Allergy. First published: 04 October 2021
Pros and cons: Should AIT be considered in all patients with allergic asthma?
Gerth van Wijk, R. and Dahl, R. Allergy. First published: 04 October 2021
Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
Smith, A.M., Ramirez, R.M., Harper, N., et al. Allergy. First published: 04 October 2021
Allergoid-mannan conjugates imprint tolerogenic features in human macrophages
Benito-Villalvilla, C., Pérez-Diego, M., Subiza, J.L. and Palomares, O. Allergy. First published: 03 October 2021
Specific T cells targeting Staphylococcus aureus Fibronectin-binding protein 1 induce a type 2/type 1 inflammatory response in sensitized atopic dermatitis patients
Farag, A.K., Roesner, L.M., Wieschowski, S., et al. Allergy. First published: 03 October 2021
Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation
Kim, J.-M., Im, Y.N., Chung, Y.-J., et al. Allergy. First published: 03 October 2021
A three-stage design for allergen immunotherapy trials
Tang, X., Rabin, R.L. and Yan, L.K. Allergy. First published: 02 October 2021
Neuron-macrophage interaction in the healing process of the skin
Soler Palacios, B. and Gutierrez, A. Allergy. First published: 02 October 2021
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear JMs,
The EAACI 2021 Annual Congress will be taking place on 10 - 12 July in a hybrid format, with both a physical part that will be held in Krakow both a digital part to allow anybody to attend safely. You are still on time to register by clicking here to have full live access to EAACI Hybrid Congress 2021 (3 days) and full access On Demand until December 31, 2021.
This is the main event of the Academy, and one of the biggest international dedicated to Allergy and Clinical Immunology. It gathers thousands of delegates from all around the world, and offers simultaneous sessions covering all aspects of our specialty.
Don't miss this opportunity and join us!
As every year the Junior Member Assembly (JMA) has organised some meetings to share knowledge and opportunity among JMs.
Here the Agenda with the highly suggested appointments:
- Monday, 28 June 2021, 15:00-16:00 CET: Open JM Business Meeting.
Invited guest Prof. Cezmi Akdis with the talk “Future direction of epithelial barrier research in the allergy and immunology field”. You can register by clicking here.
- Saturday, 10 July 2021, 14:00-15:30 CET: JMA Scientific Symposium.
Three excellent speeches on the theme "Approaching infants at high risk of allergic disease":
- Dr R. Jiménez-Saiz, “Understanding immunological mechanisms that confer a higher risk of allergy”;
- Dr M. M. Kelleher, “Infants at high risk of food allergy: nutritional and skin barrier repair interventions”;
- Dr I. Eguiluz-Gracia, “Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies”.
- Sunday, 11 July 2021, 14:00-15:30 CET: JMA Educational Session.
Composed of three very current speeches on "Lessons learned from COVID-19 pandemic":
- Dr A. DunnGalvin, “Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience”;
- “Infodemic and the lesson of the COVID-19 pandemic: how to tackle health-related misinformation”;
- Dr B. Moya, “COVID-19 vaccination: Separating facts from fiction for your patients”.
Save the dates!
Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!
Best regards,
The Junior Member Assembly
